{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:53:28Z","timestamp":1777636408976,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.04.013","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T17:39:28Z","timestamp":1587490768000},"page":"4016-4023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9\u00a0months and 2.5\u00a0years: A longitudinal study"],"prefix":"10.1016","volume":"38","author":[{"given":"Nasamon","family":"Wanlapakorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiratchaya","family":"Puenpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanunrat","family":"Thongmee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donchida","family":"Srimuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaksaporn","family":"Thatsanathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sompong","family":"Vongpunsawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-6807","authenticated-orcid":false,"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.013_b0005","unstructured":"Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand. Surveillance Data: Measles surveillance data from 2001-2018. Available from: http:\/\/www.boe.moph.go.th\/boedb\/surdata\/disease.php?dcontent=old&ds=21. [Accessed 6 Dec 2019]."},{"key":"10.1016\/j.vaccine.2020.04.013_b0010","unstructured":"Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand. Surveillance Data: Measles surveillance data in 2019. Available from: http:\/\/www.boe.moph.go.th\/boedb\/surdata\/disease.php?dcontent=situation&ds=21. [Accessed 12 Dec 2019]."},{"key":"10.1016\/j.vaccine.2020.04.013_b0015","unstructured":"Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand. Surveillance Data: Measles with complication surveillance data from 2001-2019. Available from: http:\/\/www.boe.moph.go.th\/boedb\/surdata\/disease.php?ds=22. [Accessed 12 Dec 2019]."},{"key":"10.1016\/j.vaccine.2020.04.013_b0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/jmv.23249","article-title":"Genetic characterization of measles viruses that circulated in Thailand from 1998 to 2008","volume":"84","author":"Pattamadilok","year":"2012","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.04.013_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225606","article-title":"Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey","volume":"14","author":"Wanlapakorn","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2020.04.013_b0030","unstructured":"Division of vaccine preventable diseases, Ministry of Public Health, Thailand. Vaccine coverage data in Thai children (Dashboard). Available from: https:\/\/hdcservice.moph.go.th\/hdc\/main\/index_pk.php. [Accessed 6 Jan 2020]."},{"key":"10.1016\/j.vaccine.2020.04.013_b0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.medcli.2019.01.012","article-title":"Impact of the MMR vaccine on the incidence of mumps in the Community of Madrid and evaluation of the effectiveness of the Jeryl-Lynn strain. Years 1998\u20132016","volume":"153","author":"Latasa","year":"2019","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.vaccine.2020.04.013_b0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3855\/jidc.7560","article-title":"Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program","volume":"10","author":"Ngaovithunvong","year":"2016","journal-title":"J Infect Dev Ctries."},{"key":"10.1016\/j.vaccine.2020.04.013_b0045","unstructured":"Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand. Surveillance Data: Mumps surveillance data. Available from: http:\/\/www.boe.moph.go.th\/boedb\/surdata\/disease.php?dcontent=situation&ds=52. [Accessed 6 Jan 2020]."},{"key":"10.1016\/j.vaccine.2020.04.013_b0050","unstructured":"Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand. Surveillance Data: Rubella surveillance data. Available from: http:\/\/www.boe.moph.go.th\/boedb\/surdata\/disease.php?ds=16. [Accessed 6 Jan 2020]."},{"key":"10.1016\/j.vaccine.2020.04.013_b0055","doi-asserted-by":"crossref","unstructured":"World Health Organization (WHO). Measles vaccines: WHO position paper, April 2017 - Recommendations. Vaccine. 2019;37:219\u201322. http:\/\/doi:10.1016\/j.vaccine.2017.07.066.","DOI":"10.1016\/j.vaccine.2017.07.066"},{"key":"10.1016\/j.vaccine.2020.04.013_b0060","article-title":"Quantity and quality of antibodies after acellular versus whole cell pertussis vaccines in infants born to mothers who received Tdap during pregnancy: a randomised trial","author":"Wanlapakorn","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.013_b0065","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.vaccine.2018.01.059","article-title":"Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women","volume":"36","author":"Wanlapakorn","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.013_b0070","article-title":"Seroprevalence of maternal and cord antibodies specific for diphtheria, tetanus, pertussis, measles, mumps and rubella in Shunyi, Beijing","volume":"13021","author":"Meng","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.04.013_b0075","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1473-3099(17)30307-9","article-title":"The basic reproduction number (R0) of measles: a systematic review","volume":"17","author":"Guerra","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.013_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz188","article-title":"A third dose of measles-mumps-rubella vaccine to improve immunity against mumps in young adults","author":"Kaaijk","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.013_b0085","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0140-6736(14)60539-0","article-title":"Rubella","volume":"385","author":"Lambert","year":"2015","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2020.04.013_b0090","first-page":"S701","article-title":"Antibody response after measles immunization","volume":"86","author":"Ariyasriwatana","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.vaccine.2020.04.013_b0095","first-page":"106","article-title":"Measles antibody in mothers and infants 0\u20132 years and response to measles vaccine at the age of 9 and 18 months","volume":"90","author":"Techasena","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.vaccine.2020.04.013_b0100","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1136\/bmj.c1626","article-title":"Early waning of maternal measles antibodies in era of measles elimination: longitudinal study","volume":"340","author":"Leuridan","year":"2010","journal-title":"BMJ"},{"issue":"280","key":"10.1016\/j.vaccine.2020.04.013_b0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.280.6.527","article-title":"Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months","volume":"12","author":"Gans","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.04.013_b0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1086\/421032","article-title":"Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States","volume":"190","author":"Gans","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.013_b0115","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0264-410X(98)00083-8","article-title":"Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers","volume":"16","author":"Kumar","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.013_b0120","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1086\/522519","article-title":"Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life","volume":"196","author":"Nair","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.013_b0125","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.vaccine.2019.01.043","article-title":"Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants","volume":"37","author":"Malshe","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.04.013_b0130","first-page":"309","article-title":"A comparison study of measles antibody between two doses vaccination at 9, 18 months and single dose at 9 months in children 4\u20136 years old","volume":"94","author":"Techasena","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.vaccine.2020.04.013_b0135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.vaccine.2019.11.013","article-title":"Mumps antibodies in the cord blood: Association with maternal recall of mumps. Possible consequences for vaccination strategies","volume":"38","author":"Frade","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.013_b0140","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1016\/j.vaccine.2019.05.056","article-title":"Duration of immunity to measles, rubella and mumps during the first year of life","volume":"37","author":"Cilleruelo","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.013_b0145","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00431-014-2481-5","article-title":"Susceptibility to measles, mumps, and rubella in 5-year-old children in Flanders, Belgium","volume":"174","author":"Leuridan","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2020.04.013_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2018.11.016","article-title":"Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains","volume":"25","author":"Vermeire","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2020.04.013_b0155","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1017\/S0950268818000237","article-title":"Rubella antibodies in cord blood sera in Portugal: association with maternal age and vaccination status","volume":"146","author":"Frade","year":"2018","journal-title":"Epidemiol Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2020.04.013_b0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007202","article-title":"Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial","volume":"5","author":"Lalwani","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2020.04.013_b0165","unstructured":"WHO Expert Committee on Biological Standardization: sixty-eighth report. Geneva: World Health Organization; 2018 (WHO Technical Report Series, No. 1011). p. 35-36. License: CC BY-NC-SA 3.0 IGO."},{"key":"10.1016\/j.vaccine.2020.04.013_b0170","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S1473-3099(19)30274-9","article-title":"WHO international standard for anti-rubella: learning from its application","volume":"20","author":"Kempster","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.013_b0175","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1128\/JCM.00800-16","article-title":"Where to now for standardization of anti-rubella virus IgG testing","volume":"54","author":"Dimech","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.013_b0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/CMR.00045-15","article-title":"Standardization of assays that detect anti-rubella virus IgG antibodies","volume":"29","author":"Dimech","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2020.04.013_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2015.11.022","article-title":"Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results","volume":"74","author":"Huzly","year":"2016","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.04.013_b0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-0934(99)00019-1","article-title":"Assay of humoral immunity to mumps virus","volume":"79","author":"Pipkin","year":"1999","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2020.04.013_b0195","unstructured":"Bentley M, Christian P, Heath A. National Institute for Biological Standards and Control (NIBSC). Report on a collaborative study to investigate the relationship between the 1st IRP and the 2nd and 3rd international standards for anti-measles serum\/plasma, in both ELISA and PRNT In: WHO Expert Committee on Biological Standardization. 2007. Available from: https:\/\/www.who.int\/biologicals\/BS07%202076anti-measles.pdf [Accessed 1 April 2020]."},{"key":"10.1016\/j.vaccine.2020.04.013_b0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eclinm.2019.06.010","article-title":"The effect of maternal immunisation during pregnancy on infant vaccine responses","volume":"13","author":"Zimmermann","year":"2019","journal-title":"EClinicalMedicine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:11Z","timestamp":1759401791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":40,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20304837"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9\u00a0months and 2.5\u00a0years: A longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}